EULAV Asset Management decreased its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 73.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 12,800 shares of the semiconductor company’s stock after selling 35,800 shares during the period. EULAV Asset Management’s holdings in Synopsys were worth $6,012,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Sowell Financial Services LLC grew its holdings in shares of Synopsys by 2.0% during the 4th quarter. Sowell Financial Services LLC now owns 1,056 shares of the semiconductor company’s stock worth $496,000 after acquiring an additional 21 shares during the period. Natural Investments LLC grew its holdings in shares of Synopsys by 4.6% during the 4th quarter. Natural Investments LLC now owns 482 shares of the semiconductor company’s stock worth $226,000 after acquiring an additional 21 shares during the period. Financial Management Professionals Inc. grew its holdings in shares of Synopsys by 7.0% during the 4th quarter. Financial Management Professionals Inc. now owns 335 shares of the semiconductor company’s stock worth $157,000 after acquiring an additional 22 shares during the period. Foronjy Financial LLC grew its stake in shares of Synopsys by 5.2% in the 4th quarter. Foronjy Financial LLC now owns 446 shares of the semiconductor company’s stock worth $210,000 after buying an additional 22 shares during the last quarter. Finally, Barden Capital Management Inc. grew its stake in shares of Synopsys by 1.2% in the 4th quarter. Barden Capital Management Inc. now owns 1,868 shares of the semiconductor company’s stock worth $877,000 after buying an additional 23 shares during the last quarter. Institutional investors own 85.47% of the company’s stock.
Analyst Ratings Changes
SNPS has been the topic of several recent research reports. Wells Fargo & Company upped their price target on Synopsys from $505.00 to $535.00 and gave the stock an “equal weight” rating in a research note on Thursday, May 28th. Morgan Stanley upped their price target on Synopsys from $480.00 to $525.00 and gave the stock an “equal weight” rating in a research note on Thursday, May 28th. Robert W. Baird set a $558.00 price target on Synopsys in a research note on Thursday, May 28th. BNP Paribas Exane upped their price target on Synopsys from $425.00 to $450.00 and gave the stock an “underperform” rating in a research note on Thursday, May 28th. Finally, Bank of America upped their price target on Synopsys from $515.00 to $600.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Nine research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $563.81.
Synopsys Stock Performance
Synopsys stock opened at $464.85 on Friday. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 0.33. The company has a market capitalization of $89.01 billion, a P/E ratio of 107.60, a PEG ratio of 3.01 and a beta of 1.22. The stock’s 50 day moving average is $466.55 and its 200 day moving average is $457.80. Synopsys, Inc. has a twelve month low of $376.18 and a twelve month high of $651.73.
Synopsys (NASDAQ:SNPS – Get Free Report) last released its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.15 by $0.20. The business had revenue of $2.28 billion for the quarter, compared to analysts’ expectations of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The firm’s quarterly revenue was up 41.9% on a year-over-year basis. During the same period in the prior year, the firm posted $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. On average, equities research analysts predict that Synopsys, Inc. will post 10.28 earnings per share for the current fiscal year.
Synopsys Company Profile
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Read More
- Five stocks we like better than Synopsys
- AI Server Earnings: Wall Street Sees One Clear Standout
- Navitas: NVIDIA’s AI Power Broker?
- A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below
- NVIDIA’s New Power Play: Why Fluence Is Surging
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
